Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$13.10
-1.58%
Mkt Cap $1.18B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (13 analysts)
$35.00
Range $30.00 – $40.00
Implied Upside
+167.2%
Consensus $35.00 vs current $13.10
NASDAQ·Healthcare·Biotechnology
$13.10
-1.58%
Mkt Cap $1.18B
Buy
1
Hold
0
Sell
0
Price Target (13 analysts)
$35.00
Range $30.00 – $40.00
+167.2%
Consensus $35.00 vs current $13.10